FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 334:1349-1355 May 23, 1996 Number 21 Next

	Full Text PDF Letters Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Controlled clinical trials have shown that beta-blockers can produce hemodynamic and symptomatic improvement in chronic heart failure, but the effect of these drugs on survival has not been determined.

Methods We enrolled 1094 patients with chronic heart failure in a double-blind, placebo-controlled, stratified program, in which patients were assigned to one of four treatment protocols on the basis of their exercise capacity. Within each of the four protocols patients with mild, moderate, or severe heart failure with left ventricular ejection fractions 0.35 were randomly assigned to receive either placebo (n = 398) or the beta-blocker carvedilol (n = 696); background therapy with digoxin, diuretics, and an angiotensin-converting–enzyme inhibitor remained constant. Patients were observed for the occurrence of death or hospitalization for cardiovascular reasons during the following 6 months (12 months for the group with mild heart failure).

Results The overall mortality rate was 7.8 percent in the placebo group and 3.2 percent in the carvedilol group; the reduction in risk attributable to carvedilol was 65 percent (95 percent confidence interval, 39 to 80 percent; P<0.001). This finding led the Data and Safety Monitoring Board to recommend termination of the study before its scheduled completion. In addition, as compared with placebo, carvedilol therapy was accompanied by a 27 percent reduction in the risk of hospitalization for cardiovascular causes (19.6 percent vs. 14.1 percent, P = 0.036), as well as a 38 percent reduction in the combined risk of hospitalization or death (24.6 percent vs. 15.8 percent, P<0.001). Worsening heart failure as an adverse reaction during treatment was less frequent in the carvedilol group than in the placebo group.

Conclusions Carvedilol reduces the risk of death as well as the risk of hospitalization for cardiovascular causes in patients with heart failure who are receiving treatment with digoxin, diuretics, and an angiotensin-converting–enzyme inhibitor.

Source Information

From the College of Physicians and Surgeons, Columbia University, New York (M.P.); University of Colorado Health Sciences Center, Denver (M.R.B.); University of Minnesota Medical School, Minneapolis (J.N.C.); Boston University School of Medicine, Boston (W.S.C.); Stanford University School of Medicine, Palo Alto, Calif. (M.B.F.); University of Utah School of Medicine, Salt Lake City (E.M.G.); and SmithKline Beecham Pharmaceuticals, King of Prussia, Pa. (N.H.S.).

Address reprint requests to Dr. Packer at the Division of Circulatory Physiology, Columbia University College of Physicians and Surgeons, 630 W. 168th St., New York, NY 10032.

Full Text of this Article

Related Letters:

Carvedilol in Patients with Chronic Heart Failure
Moyé L. A., Abernethy D., von Olshausen K., Pop T., Berger J., Packer M., Cohn J. N., Colucci W. S.
Extract | Full Text  
N Engl J Med 1996; 335:1318-1320, Oct 24, 1996. Correspondence

Digoxin in Patients with Heart Failure
Umans V. A., Cornel J. H., Hic C., Soto J., Avendaño C., Vilchez F. G., Böhm M., Zoneraich S., Yusuf S., Gorlin R., Garg R., Packer M.
Extract | Full Text  
N Engl J Med 1997; 337:129-131, Jul 10, 1997. Correspondence

This article has been cited by other articles:

• Triposkiadis, F., Karayannis, G., Giamouzis, G., Skoularigis, J., Louridas, G., Butler, J. (2009). The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.. J Am Coll Cardiol 54: 1747-1762 [Abstract] [Full Text]  
• Zhang, Y., Popovic, Z. B., Bibevski, S., Fakhry, I., Sica, D. A., Van Wagoner, D. R., Mazgalev, T. N. (2009). Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model. Circ Heart Fail 2: 692-699 [Abstract] [Full Text]  
• Clark, A. L., Lammiman, M. J., Goode, K., Cleland, J. G.F. (2009). Is taking part in clinical trials good for your health? A cohort study. Eur J Heart Fail 11: 1078-1083 [Abstract] [Full Text]  
• Zheng, H., Li, Y.-F., Wang, W., Patel, K. P. (2009). Enhanced angiotensin-mediated excitation of renal sympathetic nerve activity within the paraventricular nucleus of anesthetized rats with heart failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297: R1364-R1374 [Abstract] [Full Text]  
• Sperandio, P. A., Borghi-Silva, A., Barroco, A., Nery, L. E., Almeida, D. R., Neder, J. A. (2009). Microvascular oxygen delivery-to-utilization mismatch at the onset of heavy-intensity exercise in optimally treated patients with CHF. Am. J. Physiol. Heart Circ. Physiol. 297: H1720-H1728 [Abstract] [Full Text]  
• Jennings, D. L, Thompson, M. L (2009). Use of Combination Therapy with a {beta}-Blocker and Milrinone in Patients with Advanced Heart Failure. The Annals of Pharmacotherapy 43: 1872-1876 [Abstract] [Full Text]  
• Zhan, D.-Y., Morimoto, S., Du, C.-K., Wang, Y.-Y., Lu, Q.-W., Tanaka, A., Ide, T., Miwa, Y., Takahashi-Yanaga, F., Sasaguri, T. (2009). Therapeutic effect of {beta}-adrenoceptor blockers using a mouse model of dilated cardiomyopathy with a troponin mutation. Cardiovasc Res 84: 64-71 [Abstract] [Full Text]  
• Jondeau, G., Neuder, Y., Eicher, J.-C., Jourdain, P., Fauveau, E., Galinier, M., Jegou, A., Bauer, F., Trochu, J. N., Bouzamondo, A., Tanguy, M.-L., Lechat, P., for the B-CONVINCED Investigators, (2009). B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode. Eur Heart J 30: 2186-2192 [Abstract] [Full Text]  
• Dorn, G. W. II, Liggett, S. B. (2009). Mechanisms of Pharmacogenomic Effects of Genetic Variation within the Cardiac Adrenergic Network in Heart Failure. Mol. Pharmacol. 76: 466-480 [Abstract] [Full Text]  
• Hsich, E. M., Pina, I. L. (2009). Heart failure in women: a need for prospective data.. J Am Coll Cardiol 54: 491-498 [Abstract] [Full Text]  
• Klapholz, M. (2009). {beta}-Blocker Use for the Stages of Heart Failure. Mayo Clin Proc. 84: 718-729 [Abstract] [Full Text]  
• Schofer, J., Siminiak, T., Haude, M., Herrman, J. P., Vainer, J., Wu, J. C., Levy, W. C., Mauri, L., Feldman, T., Kwong, R. Y., Kaye, D. M., Duffy, S. J., Tubler, T., Degen, H., Brandt, M. C., Van Bibber, R., Goldberg, S., Reuter, D. G., Hoppe, U. C. (2009). Percutaneous Mitral Annuloplasty for Functional Mitral Regurgitation: Results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 120: 326-333 [Abstract] [Full Text]  
• Baliga, V., Sapsford, R. (2009). Review article: Diabetes mellitus and heart failure -- an overview of epidemiology and management. Diabetes and Vascular Disease Research 6: 164-171 [Abstract]  
• Bansal, S., Lindenfeld, J., Schrier, R. W. (2009). Sodium Retention in Heart Failure and Cirrhosis: Potential Role of Natriuretic Doses of Mineralocorticoid Antagonist?. Circ Heart Fail 2: 370-376 [Abstract] [Full Text]  
• De Silva, K., Katbamna, R. (2009). Principles of heart failure. InnovAiT 2: 423-429 [Abstract] [Full Text]  
• McAlister, F. A., Wiebe, N., Ezekowitz, J. A., Leung, A. A., Armstrong, P. W. (2009). Meta-analysis: {beta}-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure. ANN INTERN MED 150: 784-794 [Abstract] [Full Text]  
• Murai, H., Takamura, M., Maruyama, M., Nakano, M., Ikeda, T., Kobayashi, D., Otowa, K.-i., Ootsuji, H., Okajima, M., Furusho, H., Takata, S., Kaneko, S. (2009). Altered firing pattern of single-unit muscle sympathetic nerve activity during handgrip exercise in chronic heart failure. J. Physiol. 587: 2613-2622 [Abstract] [Full Text]  
• Krum, H. (2009). Consider {beta} blockers for patients with heart failure. BMJ 338: b1728-b1728 [Full Text]  
• Dekkers, O M, Elm, E v., Algra, A, Romijn, J A, Vandenbroucke, J P (2009). How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol 0: dyp174v1-dyp174 [Abstract] [Full Text]  
• Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: e1-e90 [Full Text]  
• Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: 1343-1382 [Full Text]  
• 2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: 1977-2016 [Full Text]  
• 2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479 [Full Text]  
• Mehta, P.A., Dubrey, S.W. (2009). High output heart failure. QJM 102: 235-241 [Abstract] [Full Text]  
• Calvert, M. J, Shankar, A., McManus, R. J, Ryan, R., Freemantle, N. (2009). Evaluation of the management of heart failure in primary care. Fam Pract 26: 145-153 [Abstract] [Full Text]  
• Shen, J.-B., Shutt, R., Agosto, M., Pappano, A., Liang, B. T. (2009). Reversal of cardiac myocyte dysfunction as a unique mechanism of rescue by P2X4 receptors in cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 296: H1089-H1095 [Abstract] [Full Text]  
• Stamato, N. J. (2009). On being critical of implantable cardioverter-defibrillator therapy.. J Am Coll Cardiol 53: 1162-1162 [Full Text]  
• Cleland, J. G.F., Cullington, D. (2009). Digoxin: Quo Vadis?. Circ Heart Fail 2: 81-85 [Full Text]  
• Erdmann, E. (2009). Safety and tolerability of beta-blockers: prejudices and reality. Eur Heart J Suppl 11: A21-A25 [Abstract] [Full Text]  
• Willenheimer, R. (2009). The current role of beta-blockers in chronic heart failure: with special emphasis on the CIBIS III trial. Eur Heart J Suppl 11: A15-A20 [Abstract] [Full Text]  
• Anand, I. S., Carson, P., Galle, E., Song, R., Boehmer, J., Ghali, J. K., Jaski, B., Lindenfeld, J., O'Connor, C., Steinberg, J. S., Leigh, J., Yong, P., Kosorok, M. R., Feldman, A. M., DeMets, D., Bristow, M. R. (2009). Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart Failure: Results From the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 119: 969-977 [Abstract] [Full Text]  
• Hernandez, A. F., Hammill, B. G., O'Connor, C. M., Schulman, K. A., Curtis, L. H., Fonarow, G. C. (2009). Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry.. J Am Coll Cardiol 53: 184-192 [Abstract] [Full Text]  
• Lewin, G., Matus, M., Basu, A., Frebel, K., Rohsbach, S. P., Safronenko, A., Seidl, M. D., Stumpel, F., Buchwalow, I., Konig, S., Engelhardt, S., Lohse, M. J., Schmitz, W., Muller, F. U. (2009). Critical Role of Transcription Factor Cyclic AMP Response Element Modulator in {beta}1-Adrenoceptor-Mediated Cardiac Dysfunction. Circulation 119: 79-88 [Abstract] [Full Text]  
• McMurray, J., Petrie, M., Swedberg, K., Komajda, M., Anker, S., Gardner, R. (2009). CHAPTER 23 Heart Failure. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
• Go, A. S., Yang, J., Gurwitz, J. H., Hsu, J., Lane, K., Platt, R. (2008). Comparative Effectiveness of Different {beta}-Adrenergic Antagonists on Mortality Among Adults With Heart Failure in Clinical Practice. Arch Intern Med 168: 2415-2421 [Abstract] [Full Text]  
• Kramer, J. M., Curtis, L. H., Dupree, C. S., Pelter, D., Hernandez, A., Massing, M., Anstrom, K. J. (2008). Comparative Effectiveness of {beta}-Blockers in Elderly Patients With Heart Failure. Arch Intern Med 168: 2422-2428 [Abstract] [Full Text]  
• Pitt, B. (2008). Comparative Effectiveness of {beta}-Blockers in Elderly Patients With Heart Failure--Invited Commentary. Arch Intern Med 168: 2431-2432 [Full Text]  
• Curtis, L. H., Greiner, M. A., Hammill, B. G., Kramer, J. M., Whellan, D. J., Schulman, K. A., Hernandez, A. F. (2008). Early and Long-term Outcomes of Heart Failure in Elderly Persons, 2001-2005. Arch Intern Med 168: 2481-2488 [Abstract] [Full Text]  
• Holubarsch, C. J.F., Colucci, W. S., Meinertz, T., Gaus, W., Tendera, M., Survival and Prognosis: Investigation of Crataegus, (2008). The efficacy and safety of Crataegus extract WS(R) 1442 in patients with heart failure: The SPICE trial. Eur J Heart Fail 10: 1255-1263 [Abstract] [Full Text]  
• Pasquali, S. K., Hall, M., Slonim, A. D., Jenkins, K. J., Marino, B. S., Cohen, M. S., Shah, S. S. (2008). Off-Label Use of Cardiovascular Medications in Children Hospitalized With Congenital and Acquired Heart Disease. Circ Cardiovasc Qual Outcomes 1: 74-83 [Abstract] [Full Text]  
• Mehta, P. A., Dubrey, S. W., McIntyre, H. F., Walker, D. M., Hardman, S. M.C., Sutton, G. C., McDonagh, T. A., Cowie, M. R. (2008). Mode of death in patients with newly diagnosed heart failure in the general population. Eur J Heart Fail 10: 1108-1116 [Abstract] [Full Text]  
• Tribouilloy, C, Rusinaru, D, Mahjoub, H, Tartiere, J-M, Kesri-Tartiere, L, Godard, S, Peltier, M (2008). Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective five-year study. Heart 94: 1450-1455 [Abstract] [Full Text]  
• Johnson, J. A. (2008). Ethnic Differences in Cardiovascular Drug Response: Potential Contribution of Pharmacogenetics. Circulation 118: 1383-1393 [Full Text]  
• Remme, W. J., McMurray, J. J.V., Hobbs, F.D. R., Cohen-Solal, A., Lopez-Sendon, J., Boccanelli, A., Zannad, F., Rauch, B., Keukelaar, K., Macarie, C., Ruzyllo, W., Cline, C., for the SHAPE Study Group, (2008). Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. Eur Heart J 29: 1739-1752 [Abstract] [Full Text]  
• Nishii, M., Inomata, T., Takehana, H., Naruke, T., Yanagisawa, T., Moriguchi, M., Takeda, S., Izumi, T. (2008). Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.. J Am Coll Cardiol 51: 2329-2335 [Abstract] [Full Text]  
• Couchonnal, L. F., Anderson, M. E. (2008). The Role of Calmodulin Kinase II in Myocardial Physiology and Disease. Physiology 23: 151-159 [Abstract] [Full Text]  
• Moye, L. A (2008). Disciplined analyses in clinical trials: the dark heart of the matter. Stat Methods Med Res 17: 253-264 [Abstract]  
• Kasama, S., Toyama, T., Sumino, H., Nakazawa, M., Matsumoto, N., Sato, Y., Kumakura, H., Takayama, Y., Ichikawa, S., Suzuki, T., Kurabayashi, M. (2008). Prognostic Value of Serial Cardiac 123I-MIBG Imaging in Patients with Stabilized Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction. JNM 49: 907-914 [Abstract] [Full Text]  
• Beer, M., Wagner, D., Myers, J., Sandstede, J., Kostler, H., Hahn, D., Neubauer, S., Dubach, P. (2008). Effects of Exercise Training on Myocardial Energy Metabolism and Ventricular Function Assessed by Quantitative Phosphorus-31 Magnetic Resonance Spectroscopy and Magnetic Resonance Imaging in Dilated Cardiomyopathy. J Am Coll Cardiol 51: 1883-1891 [Abstract] [Full Text]  
• Eisen, H. J. (2008). Exercise Training and Myocardial Energetics in Patients With Heart Failure: When More Is Less. J Am Coll Cardiol 51: 1892-1895 [Full Text]  
• Nishio, M., Sakata, Y., Mano, T., Ohtani, T., Takeda, Y., Miwa, T., Hori, M., Masuyama, T., Kondo, T., Yamamoto, K. (2008). Beneficial effects of bisoprolol on the survival of hypertensive diastolic heart failure model rats. Eur J Heart Fail 10: 446-453 [Abstract] [Full Text]  
• Hansen, M. L., Gadsboll, N., Gislason, G. H., Abildstrom, S. Z., Schramm, T. K., Folke, F., Friberg, J., Sorensen, R., Rasmussen, S., Poulsen, H. E., Kober, L., Madsen, M., Torp-Pedersen, C. (2008). Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers. Europace 10: 395-402 [Abstract] [Full Text]  
• Chupp, G. L. (2008). Say What, Beta-Blockers for Asthma?. Am. J. Respir. Cell Mol. Bio. 38: 249-250 [Full Text]  
• Fantoni, C., Regoli, F., Ghanem, A., Raffa, S., Klersy, C., Sorgente, A., Faletra, F., Baravelli, M., Inglese, L., Salerno-Uriarte, J. A., Klein, H. U., Moccetti, T., Auricchio, A. (2008). Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy. Eur J Heart Fail 10: 298-307 [Abstract] [Full Text]  
• Xu-Cai, Y. O., Brotman, D. J., Phillips, C. O., Michota, F. A., Tang, W. H. W., Whinney, C. M., Panneerselvam, A., Hixson, E. D., Garcia, M., Francis, G. S., Jaffer, A. K. (2008). Outcomes of Patients With Stable Heart Failure Undergoing Elective Noncardiac Surgery. Mayo Clin Proc. 83: 280-288 [Abstract] [Full Text]  
• Albert, N. M. (2007). Switching to Once-Daily Evidence-Based -Blockers in Patients With Systolic Heart Failure or Left Ventricular Dysfunction After Myocardial Infarction. Crit Care Nurse 27: 62-72 [Full Text]  
• Buettner, H. J., Mueller, C. (2007). Effects of obesity on mortality in patients with unstable angina or non-ST-elevation myocardial infarction: reply. Eur Heart J 28: 2950-2951 [Full Text]  
• Remme, W. J. (2007). Filling the gap between guidelines and clinical practice in heart failure treatment -- Still a far cry from reality. Eur J Heart Fail 9: 1143-1145 [Full Text]  
• Triller, D. M., Hamilton, R. A. (2007). Effect of pharmaceutical care services on outcomes for home care patients with heart failure. Am J Health Syst Pharm 64: 2244-2249 [Abstract] [Full Text]  
• Remme, W. J., Cleland, J. G., Erhardt, L., Spark, P., Torp-Pedersen, C., Metra, M., Komajda, M., Moullet, C., Lukas, M. A., Poole-Wilson, P., Di Lenarda, A., Swedberg, K. (2007). Effect of carvedilol and metoprolol on the mode of death in patients with heart failure. Eur J Heart Fail 9: 1128-1135 [Abstract] [Full Text]  
• Fauchier, L., Pierre, B., de Labriolle, A., Babuty, D. (2007). Comparison of the beneficial effect of beta-blockers on mortality in patients with ischaemic or non-ischaemic systolic heart failure: A meta-analysis of randomised controlled trials. Eur J Heart Fail 9: 1136-1139 [Abstract] [Full Text]  
• Tsukamoto, T., Morita, K., Naya, M., Inubushi, M., Katoh, C., Nishijima, K., Kuge, Y., Okamoto, H., Tsutsui, H., Tamaki, N. (2007). Decreased Myocardial {beta}-Adrenergic Receptor Density in Relation to Increased Sympathetic Tone in Patients with Nonischemic Cardiomyopathy. JNM 48: 1777-1782 [Abstract] [Full Text]  
• Schwartz, P. J., Vanoli, E. (2007). From exercise training to sudden death prevention via adrenergic receptors. Am. J. Physiol. Heart Circ. Physiol. 293: H2631-H2633 [Full Text]  
• Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., Lefkowitz, R. J. (2007). A unique mechanism of beta-blocker action: Carvedilol stimulates beta-arrestin signaling. Proc. Natl. Acad. Sci. USA 104: 16657-16662 [Abstract] [Full Text]  
• Okumura, S., Vatner, D. E., Kurotani, R., Bai, Y., Gao, S., Yuan, Z., Iwatsubo, K., Ulucan, C., Kawabe, J.-i., Ghosh, K., Vatner, S. F., Ishikawa, Y. (2007). Disruption of Type 5 Adenylyl Cyclase Enhances Desensitization of Cyclic Adenosine Monophosphate Signal and Increases Akt Signal With Chronic Catecholamine Stress. Circulation 116: 1776-1783 [Abstract] [Full Text]  
• Shaddy, R. E., Boucek, M. M., Hsu, D. T., Boucek, R. J., Canter, C. E., Mahony, L., Ross, R. D., Pahl, E., Blume, E. D., Dodd, D. A., Rosenthal, D. N., Burr, J., LaSalle, B., Holubkov, R., Lukas, M. A., Tani, L. Y., For the Pediatric Carvedilol Study Group, (2007). Carvedilol for Children and Adolescents With Heart Failure: A Randomized Controlled Trial. JAMA 298: 1171-1179 [Abstract] [Full Text]  
• Gidding, S. S. (2007). The Importance of Randomized Controlled Trials in Pediatric Cardiology. JAMA 298: 1214-1216 [Full Text]  
• Metra, M., Torp-Pedersen, C., Cleland, J. G.F., Di Lenarda, A., Komajda, M., Remme, W. J., Cas, L. D., Spark, P., Swedberg, K., Poole-Wilson, P. A., for the COMET investigators, (2007). Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. Eur J Heart Fail 9: 901-909 [Abstract] [Full Text]  
• Gustafsson, F., Schou, M., Videbaek, L., Nielsen, T., Ulriksen, H., Markenvard, J., Svendsen, T. L., Ryde, H., Vigholt, E., Hildebrandt, P., on behalf of the Danish Heart Failure Clinics Netw, (2007). Treatment with beta-blockers in nurse-led heart failure clinics: Titration efficacy and predictors of failure. Eur J Heart Fail 9: 910-916 [Abstract] [Full Text]  
• Swedberg, K. (2007). Pure heart rate reduction: further perspectives in heart failure. Eur Heart J Suppl 9: F20-F24 [Abstract] [Full Text]  
• Agostoni, P., Contini, M., Cattadori, G., Apostolo, A., Sciomer, S., Bussotti, M., Palermo, P., Fiorentini, C. (2007). Lung function with carvedilol and bisoprolol in chronic heart failure: Is {beta} selectivity relevant?. Eur J Heart Fail 9: 827-833 [Abstract] [Full Text]  
• Colucci, W. S., Kolias, T. J., Adams, K. F., Armstrong, W. F., Ghali, J. K., Gottlieb, S. S., Greenberg, B., Klibaner, M. I., Kukin, M. L., Sugg, J. E., on behalf of the REVERT Study Group, (2007). Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic Dysfunction: The REversal of VEntricular Remodeling with Toprol-XL (REVERT) Trial. Circulation 116: 49-56 [Abstract] [Full Text]  
• Patel, J., Heywood, J. T. (2007). Mode of Death in Patients With Systolic Heart Failure. J CARDIOVASC PHARMACOL THER 12: 127-136 [Abstract]  
• Fedoruk, L. M., Tribble, C. G., Kern, J. A., Peeler, B. B., Kron, I. L. (2007). Predicting Operative Mortality After Surgery for Ischemic Cardiomyopathy. Ann. Thorac. Surg. 83: 2029-2035 [Abstract] [Full Text]  
• Matus, M., Lewin, G., Stumpel, F., Buchwalow, I. B., Schneider, M. D., Schutz, G., Schmitz, W., Muller, F. U. (2007). Cardiomyocyte-specific inactivation of transcription factor CREB in mice. FASEB J. 21: 1884-1892 [Abstract] [Full Text]  
• Johnson, M. J (2007). Management of end stage cardiac failure. Postgrad. Med. J. 83: 395-401 [Abstract] [Full Text]  
• Cheng, Y., George, I., Yi, G.-H., Reiken, S., Gu, A., Tao, Y. K., Muraskin, J., Qin, S., He, K.-L., Hay, I., Yu, K., Oz, M. C., Burkhoff, D., Holmes, J., Wang, J. (2007). Bradycardic Therapy Improves Left Ventricular Function and Remodeling in Dogs with Coronary Embolization-Induced Chronic Heart Failure. J. Pharmacol. Exp. Ther. 321: 469-476 [Abstract] [Full Text]  
• Gentile, C. L., Orr, J. S., Davy, B. M., Davy, K. P. (2007). Modest weight gain is associated with sympathetic neural activation in nonobese humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292: R1834-R1838 [Abstract] [Full Text]  
• Kasama, S., Toyama, T., Hatori, T., Sumino, H., Kumakura, H., Takayama, Y., Ichikawa, S., Suzuki, T., Kurabayashi, M. (2007). Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol. Eur Heart J 0: ehm048v1-7 [Abstract] [Full Text]  
• Frazier, C. G., Alexander, K. P., Newby, L. K., Anderson, S., Iverson, E., Packer, M., Cohn, J., Goldstein, S., Douglas, P. S. (2007). Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic Dysfunction: A Pooled Analysis of 5 Randomized Control Trials. J Am Coll Cardiol 49: 1450-1458 [Abstract] [Full Text]  
• Hauptman, P. J., Sabbah, H. N. (2007). Reversal of ventricular remodeling: Important to establish and difficult to define. Eur J Heart Fail 9: 325-328 [Full Text]  
• Berry, C., Murphy, N., De Vito, G., Galloway, S., Seed, A., Fisher, C., Sattar, N., Vallance, P., Hillis, W. S., McMurray, J. (2007). Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker. Eur J Heart Fail 9: 429-434 [Abstract] [Full Text]  
• Neubauer, S. (2007). The Failing Heart -- An Engine Out of Fuel. NEJM 356: 1140-1151 [Full Text]  
• Allen, L. A., O'Connor, C. M. (2007). Management of acute decompensated heart failure. CMAJ 176: 797-805 [Abstract] [Full Text]  
• Remme, W. J., Torp-Pedersen, C., Cleland, J. G.F., Poole-Wilson, P. A., Metra, M., Komajda, M., Swedberg, K., Di Lenarda, A., Spark, P., Scherhag, A., Moullet, C., Lukas, M. A. (2007). Carvedilol Protects Better Against Vascular Events Than Metoprolol in Heart Failure: Results From COMET. J Am Coll Cardiol 49: 963-971 [Abstract] [Full Text]  
• Jin, Y.-T., Hasebe, N., Matsusaka, T., Natori, S., Ohta, T., Tsuji, S., Kikuchi, K. (2007). Magnesium attenuates isoproterenol-induced acute cardiac dysfunction and beta-adrenergic desensitization. Am. J. Physiol. Heart Circ. Physiol. 292: H1593-H1599 [Abstract] [Full Text]  
• Takemoto, Y., Hozumi, T., Sugioka, K., Takagi, Y., Matsumura, Y., Yoshiyama, M., Abraham, T. P., Yoshikawa, J. (2007). Beta-Blocker Therapy Induces Ventricular Resynchronization in Dilated Cardiomyopathy With Narrow QRS Complex. J Am Coll Cardiol 49: 778-783 [Abstract] [Full Text]